(Q36156185)

English

LC-MS/MS method development for quantification of doxorubicin and its metabolite 13-hydroxy doxorubicin in mice biological matrices: Application to a pharmaco-delivery study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

LC-MS/MS method development for quantification of doxorubicin and its metabolite 13-hydroxy doxorubicin in mice biological matrices: Application to a pharmaco-delivery study (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

object named as

Roberta Ottria

7

0 references

Serena Mazzucchelli

object named as

Serena Mazzucchelli

1

0 references

object named as

Fabio Corsi

5

0 references

Pierangela Ciuffreda

object named as

Pierangela Ciuffreda

6

0 references

author name string

Alessandro Ravelli

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Fausto Gigli

3

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Mauro Minoli

4

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

7 October 2016

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Biomedical Chromatography

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Selective determination of doxorubicin and doxorubicinol in rat plasma by HPLC with photosensitization reaction followed by chemiluminescence detection.

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

Doxil®--the first FDA-approved nano-drug: lessons learned

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

Monitoring the subcellular localization of doxorubicin in CHO-K1 using MEKC-LIF: liposomal carrier for enhanced drug delivery

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

Extraction protocol and mass spectrometry method for quantification of doxorubicin released locally from prodrugs in tumor tissue

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

Quantification of pegylated liposomal doxorubicin and doxorubicinol in rat plasma by liquid chromatography/electrospray tandem mass spectroscopy: Application to preclinical pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

Quantitative liquid chromatographic analysis of anthracyclines in biological fluids.

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

PEGylated PLGA nanoparticles for the improved delivery of doxorubicin

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells.

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

Simultaneous measurement of doxorubicin and reduced metabolite doxorubicinol by UHPLC-MS/MS in human plasma of HCC patients treated with TACE.

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

H-Chain Ferritin: A Natural Nuclei Targeting and Bioactive Delivery Nanovector

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

Determination of doxorubicin and its metabolites in rat serum and bile by LC: application to preclinical pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1002%2FBMC.3863

21 January 2018

Identifiers

10.1002/BMC.3863

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36156185&oldid=1968210771"